Compare TALK & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TALK | BTX |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | 521 | N/A |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 788.5M | 780.8M |
| IPO Year | N/A | N/A |
| Metric | TALK | BTX |
|---|---|---|
| Price | $5.14 | $6.48 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.42 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 650.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.02 | N/A |
| Revenue Next Year | $21.24 | N/A |
| P/E Ratio | $155.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.22 | $5.10 |
| 52 Week High | $5.19 | $7.50 |
| Indicator | TALK | BTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.44 | 48.65 |
| Support Level | $4.59 | $6.23 |
| Resistance Level | $5.19 | $6.94 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 91.41 | 49.15 |
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.